Although the precise mechanisms underlying KYNU overexpression and its role in GBM progression remain unclear, analysis of larger datasets—including information on genetic alterations in KYNU and related pathways—will be necessary to better understand its upstream regulation and prognostic significance. The gene discussed is KYNU; the disease is glioblastoma.